Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 9.41 Million USD | 9.69% |
| 2019 | 8.58 Million USD | 2.38% |
| 2018 | 8.38 Million USD | 8.8% |
| 2017 | 7.7 Million USD | -26.63% |
| 2016 | 10.5 Million USD | 6.19% |
| 2015 | 9.89 Million USD | 1931.2% |
| 2014 | 487.17 Thousand USD | 16.06% |
| 2013 | 419.77 Thousand USD | 74.24% |
| 2012 | 240.91 Thousand USD | -26.67% |
| 2011 | 328.54 Thousand USD | -91.49% |
| 2010 | 3.86 Million USD | -72.57% |
| 2009 | 14.08 Million USD | 9.9% |
| 2008 | 12.81 Million USD | -18.94% |
| 2007 | 15.8 Million USD | 1057.0% |
| 2006 | 1.36 Million USD | 73.4% |
| 2005 | 787.8 Thousand USD | 41.99% |
| 2004 | 554.82 Thousand USD | 0.0% |
| 2002 | 137.95 Thousand USD | -41.9% |
| 2001 | 237.44 Thousand USD | 237.29% |
| 2000 | 70.39 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2021 Q1 | 9.53 Million USD | 1.27% |
| 2021 FY | - USD | -100.0% |
| 2021 Q3 | 505.68 Thousand USD | -77.28% |
| 2021 Q2 | 2.22 Million USD | -76.67% |
| 2020 Q2 | 9.57 Million USD | 8.07% |
| 2020 Q1 | 8.85 Million USD | 3.14% |
| 2020 Q4 | 9.41 Million USD | 1.23% |
| 2020 Q3 | 9.3 Million USD | -2.8% |
| 2020 FY | 9.41 Million USD | 9.69% |
| 2019 Q3 | 8.57 Million USD | -0.12% |
| 2019 FY | 8.58 Million USD | 2.38% |
| 2019 Q4 | 8.58 Million USD | 0.15% |
| 2019 Q2 | 8.58 Million USD | 0.77% |
| 2019 Q1 | 8.51 Million USD | 1.56% |
| 2018 Q4 | 8.38 Million USD | 2.75% |
| 2018 FY | 8.38 Million USD | 8.8% |
| 2018 Q3 | 8.16 Million USD | 5.22% |
| 2018 Q2 | 7.75 Million USD | 0.87% |
| 2018 Q1 | 7.69 Million USD | -0.23% |
| 2017 Q2 | 11.24 Million USD | 5.96% |
| 2017 Q1 | 10.61 Million USD | 1.03% |
| 2017 FY | 7.7 Million USD | -26.63% |
| 2017 Q4 | 7.7 Million USD | 0.84% |
| 2017 Q3 | 7.64 Million USD | -32.04% |
| 2016 Q1 | 9.57 Million USD | 1610.33% |
| 2016 Q4 | 10.5 Million USD | -4.56% |
| 2016 FY | 10.5 Million USD | 6.19% |
| 2016 Q3 | 11.01 Million USD | 5.09% |
| 2016 Q2 | 10.47 Million USD | 9.38% |
| 2015 Q3 | 488.17 Thousand USD | 1.58% |
| 2015 Q2 | 480.57 Thousand USD | -1.35% |
| 2015 Q4 | 560.06 Thousand USD | 14.73% |
| 2015 FY | 9.89 Million USD | 1931.2% |
| 2015 Q1 | 487.17 Thousand USD | 10.59% |
| 2014 FY | 487.17 Thousand USD | 16.06% |
| 2014 Q3 | 432.81 Thousand USD | 10.81% |
| 2014 Q1 | 419.77 Thousand USD | 19.6% |
| 2014 Q4 | 440.52 Thousand USD | 1.78% |
| 2014 Q2 | 390.6 Thousand USD | -6.95% |
| 2013 Q2 | 264.84 Thousand USD | 9.93% |
| 2013 Q1 | 240.91 Thousand USD | -38.73% |
| 2013 FY | 419.77 Thousand USD | 74.24% |
| 2013 Q4 | 350.98 Thousand USD | 16.18% |
| 2013 Q3 | 302.11 Thousand USD | 14.08% |
| 2012 Q2 | 294.2 Thousand USD | -10.45% |
| 2012 FY | 240.91 Thousand USD | -26.67% |
| 2012 Q3 | 329.52 Thousand USD | 12.01% |
| 2012 Q1 | 328.54 Thousand USD | -90.81% |
| 2012 Q4 | 393.17 Thousand USD | 19.31% |
| 2011 FY | 328.54 Thousand USD | -91.49% |
| 2011 Q4 | 3.57 Million USD | -7.66% |
| 2011 Q3 | 3.87 Million USD | -2.24% |
| 2011 Q1 | 3.86 Million USD | -36.73% |
| 2011 Q2 | 3.96 Million USD | 2.59% |
| 2010 Q4 | 6.1 Million USD | -56.95% |
| 2010 Q1 | 14.08 Million USD | 1.83% |
| 2010 Q2 | 14.43 Million USD | 2.52% |
| 2010 FY | 3.86 Million USD | -72.57% |
| 2010 Q3 | 14.17 Million USD | -1.77% |
| 2009 FY | 14.08 Million USD | 9.9% |
| 2009 Q1 | 12.81 Million USD | -10.79% |
| 2009 Q2 | 12.63 Million USD | -1.4% |
| 2009 Q3 | 13.18 Million USD | 4.35% |
| 2009 Q4 | 13.82 Million USD | 4.9% |
| 2008 Q2 | 15.59 Million USD | -1.33% |
| 2008 Q4 | 14.36 Million USD | -9.4% |
| 2008 FY | 12.81 Million USD | -18.94% |
| 2008 Q1 | 15.8 Million USD | 31.66% |
| 2008 Q3 | 15.85 Million USD | 1.65% |
| 2007 Q1 | 1.36 Million USD | 159.23% |
| 2007 Q2 | 1.21 Million USD | -11.09% |
| 2007 Q3 | 11.83 Million USD | 874.58% |
| 2007 Q4 | 12 Million USD | 1.41% |
| 2007 FY | 15.8 Million USD | 1057.0% |
| 2006 Q3 | 422.15 Thousand USD | 14.98% |
| 2006 Q1 | 787.8 Thousand USD | 37.15% |
| 2006 FY | 1.36 Million USD | 73.4% |
| 2006 Q4 | 526.97 Thousand USD | 24.83% |
| 2006 Q2 | 367.17 Thousand USD | -53.39% |
| 2005 Q4 | 574.4 Thousand USD | 36.94% |
| 2005 Q1 | 554.82 Thousand USD | 5766.32% |
| 2005 Q3 | 419.45 Thousand USD | -1.55% |
| 2005 FY | 787.8 Thousand USD | 41.99% |
| 2005 Q2 | 426.05 Thousand USD | -23.21% |
| 2004 Q2 | 32.59 Thousand USD | -93.04% |
| 2004 Q1 | 468.23 Thousand USD | 300.66% |
| 2004 FY | 554.82 Thousand USD | 0.0% |
| 2004 Q4 | 9457.73 USD | -96.52% |
| 2004 Q3 | 271.84 Thousand USD | 734.11% |
| 2003 Q1 | 112.47 Thousand USD | 10.68% |
| 2003 Q4 | 116.86 Thousand USD | -37.09% |
| 2003 Q3 | 185.78 Thousand USD | 34.67% |
| 2003 Q2 | 137.95 Thousand USD | 22.65% |
| 2002 Q3 | 261.54 Thousand USD | 10.15% |
| 2002 Q1 | 37.97 Thousand USD | 187.25% |
| 2002 Q2 | 237.44 Thousand USD | 525.27% |
| 2002 Q4 | 101.61 Thousand USD | -61.15% |
| 2002 FY | 137.95 Thousand USD | -41.9% |
| 2001 Q4 | 13.22 Thousand USD | -70.06% |
| 2001 FY | 237.44 Thousand USD | 237.29% |
| 2001 Q3 | 44.14 Thousand USD | 0.0% |
| 2000 FY | 70.39 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 100.0% |
| BioElectronics Corporation | 16.62 Million USD | 100.0% |
| CVR Medical Corp. | - USD | NaN% |
| IR-Med Inc. | 634 Thousand USD | 100.0% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | 100.0% |
| Polarean Imaging plc | 2.58 Million USD | 100.0% |
| AVITA Medical, Inc. | 19.86 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 100.0% |
| Össur hf. | 688.8 Million USD | 100.0% |
| Zecotek Photonics Inc. | 5.86 Million USD | 100.0% |
| QHSLab, Inc. | 2.05 Million USD | 100.0% |
| Wellstar International, Inc. | 55.99 Million USD | 100.0% |
| Össur hf. | 688.8 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 100.0% |
| Escalon Medical Corp. | 2.94 Million USD | 100.0% |
| Aurora Spine Corporation | 6.65 Million USD | 100.0% |
| BrainsWay Ltd. | 15.31 Million USD | 100.0% |
| NewCardio, Inc. | 6.01 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 100.0% |
| Vivos Inc. | 245 Thousand USD | 100.0% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 100.0% |
| Kelyniam Global, Inc. | 1.01 Million USD | 100.0% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 100.0% |
| Nanomix Corporation | 14.81 Million USD | 100.0% |
| Theraclion SA | 13.01 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 5.12 Million USD | 100.0% |
| Positron Corporation | 2.02 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 100.0% |
| Lombard Medical, Inc. | 53.79 Million USD | 100.0% |
| ALR Technologies Inc. | 24.5 Million USD | 100.0% |
| Stratec SE | 271.97 Million USD | 100.0% |
| Vycor Medical, Inc. | 4.31 Million USD | 100.0% |
| Heart Tronics, Inc. | 1.09 Million USD | 100.0% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 100.0% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 201.36 USD | 100.0% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 100.0% |
| Ingen Technologies, Inc. | 5.7 Million USD | 100.0% |
| Odyssey Group International, Inc. | 6.61 Million USD | 100.0% |
| United American Healthcare Corporation | 119 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | 11.94 Million USD | 100.0% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 100.0% |
| Urologix, Inc. | 12.64 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 100.0% |
| SS Innovations International, Inc. | 11.18 Million USD | 100.0% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | 100.0% |
| Smith & Nephew plc | 4.76 Billion USD | 100.0% |
| NIOX Group Plc | 9.8 Million USD | 100.0% |
| Fuse Medical, Inc. | 15.11 Million USD | 100.0% |
| Broncus Holding Corporation | 10.43 Million USD | 100.0% |
| Brain Scientific Inc. | 7.42 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 100.0% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | 100.0% |